The airway microbiome in cystic fibrosis and implications for treatment.
about
The microbiome of the lungPotential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistanceBacterial quorum sensing: its role in virulence and possibilities for its controlThe airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementModelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host responseTangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infectionsBreath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.Ecological networking of cystic fibrosis lung infections.Characterization of bacterial communities in venous insufficiency wounds by use of conventional culture and molecular diagnostic methods.Assessment of microbial diversity in biofilms recovered from endotracheal tubes using culture dependent and independent approachesSerial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposuresNovosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies.Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections.The microbiome of the upper airways: focus on chronic rhinosinusitis.Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa.Human pharyngeal microbiome may play a protective role in respiratory tract infections.Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1Future directions in early cystic fibrosis lung disease research: an NHLBI workshop reportData Mining of Lung Microbiota in Cystic Fibrosis Patients.Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.The innate immune function of airway epithelial cells in inflammatory lung diseaseEffect of Advanced HIV Infection on the Respiratory MicrobiomeNovel therapeutic strategies to counter Pseudomonas aeruginosa infections.The challenges and promises of new therapies for cystic fibrosis.Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.When being alone is enough: noncanonical functions of canonical bacterial quorum-sensing systems.The talking language in some major Gram-negative bacteria.Lung microbiome in human immunodeficiency virus infection.Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilmsUnderstanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic FibrosisInfection prevention and control guideline for cystic fibrosis: 2013 update.Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial.Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children.Variance Component Selection With Applications to Microbiome Taxonomic Data.
P2860
Q24602074-18941289-F3CE-4CFE-AFE4-D80FD110AFDFQ26798603-1063F5C4-B2A4-41D3-A8C7-A6F946B23AEAQ26830110-B656B248-9C7C-4198-BC56-1FDBA8C97565Q28730299-815734E3-9D7F-46BD-A697-A9AEEB944248Q30394473-C23C8407-2C04-4158-ADC3-9C2FC4EBE901Q33455287-B336AFC0-3A56-4B88-8095-41A26E56A9A8Q33647129-9915F7FD-2249-447D-8ADF-F2C0D59CDFAFQ33767505-369E454E-A32F-4BFE-AEEA-71C5EA165736Q34006801-48A744C9-746A-45E1-8C48-4FA734E813D7Q34302557-3D8BE9F1-F75A-4C4D-B6EF-A466DBBC03C9Q34388328-27954171-6342-439E-A68F-7464E8E1666AQ34395556-771A6108-E017-47A8-AF21-2E75CB91E222Q34755870-AE35DCBE-EF60-4ADC-A495-863615D94832Q35012395-78EA96E0-1AD9-4536-98A2-CA1E46E5008EQ35109394-626C661E-33DF-40AF-B300-0F12A4E0E80FQ35192938-FEB69410-4147-400D-B618-86B7B9EAFC1EQ35597064-B922C351-6818-4703-B94A-081C2A159897Q35988949-3EBD79E0-6DAA-4304-9B0F-5B02DE32BD69Q36163849-E4E71718-F9A0-45C9-B064-5D65AB0064D7Q36187491-FC0CA3A9-4D26-4102-A47E-87ADFE725A20Q36213685-8C695494-15B5-4C8D-89D1-B5AF4F94C42EQ36481368-B1B386EF-7D25-463D-9235-4C0573D6CE12Q37213594-E92D7F4E-ED27-41A1-B1AA-FD298B6EFC00Q37984505-B6992ED6-5D05-470C-A51F-EF0DFD8BB72EQ38023386-18A773E9-4CF2-47EA-AAC4-40F99B094BE3Q38101836-E58384C8-71D4-49ED-B9BE-1CC4A7F5399AQ38796210-0EABCDA7-AC03-421A-8AAB-7D6B4F74FB0AQ38803545-70DD4072-B490-420B-86A2-C3BC0B0DAE0FQ38803603-C2801B46-12EA-43CF-BA67-705014C0E77CQ38920108-58FF5134-A058-4736-A97B-058684EF59F5Q39167799-9A3D96CE-38E4-4E9B-9BB6-0B9317C15CADQ39253846-4620B54D-72B0-47EB-997C-146963257516Q42206103-5C07BB89-D730-4895-8C32-626DB6ADEBECQ46257031-CF1512DC-A9A6-40C5-AC49-B92EE7C27BBEQ46263483-A64ACFA2-A26D-4F7A-841C-46AC263B7BFEQ47653765-8C159304-BA25-45CA-9F67-AFBAB557AC5DQ54237360-4D3FE46A-06FE-440E-91AA-61A91CD981A4
P2860
The airway microbiome in cystic fibrosis and implications for treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The airway microbiome in cystic fibrosis and implications for treatment.
@ast
The airway microbiome in cystic fibrosis and implications for treatment.
@en
type
label
The airway microbiome in cystic fibrosis and implications for treatment.
@ast
The airway microbiome in cystic fibrosis and implications for treatment.
@en
prefLabel
The airway microbiome in cystic fibrosis and implications for treatment.
@ast
The airway microbiome in cystic fibrosis and implications for treatment.
@en
P1476
The airway microbiome in cystic fibrosis and implications for treatment.
@en
P2093
Jonathan K Harris
Scott D Sagel
P304
P356
10.1097/MOP.0B013E32834604F2
P577
2011-06-01T00:00:00Z